跳至主要内容
临床试验/CTRI/2020/05/025067
CTRI/2020/05/025067已完成未知

A randomized controlled trial of hydroxychloroquine prophylaxis for Healthcare Workers exposed to COVID-19

George Institute for Global Health India0 个研究点目标入组 416 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
416

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All HCWs directly exposed to confirmed COVID-19 patients.

排除标准

  • Participants who meet any of following criteria will be are excluded
  • 1. have a proven diagnosis of COVID-19 infection
  • 2. are currently taking chloroquine or HCQ
  • 3. are pregnant
  • 4. are breast feeding
  • 5. known QT prolongation
  • 6. history of serious cardiac dysrhythmias or cardiomyopathy
  • 7. have maculopathy of the eye (a contra-indication to HCQ)
  • 8. are immunocompromised because of a disease or therapy
  • 9. pregnant women

研究者

发起方
George Institute for Global Health India

相似试验

进行中(未招募)
1 期
Randomized controlled trial of hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of elderly COVID-19 PatientsCoronavirus disease
EUCTR2020-001482-37-DEniversity Hopsital Tuebingen350
进行中(未招募)
1 期
Systematic study of the medicine hydroxychloroquine against placebo for the treatment of adult patients with acute coronavirus disease 2019 – COVID-19Acute coronavirus disease 2019MedDRA version: 20.1Level: PTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2020-001224-33-DEniversitätsklinikum Tübingen220
进行中(未招募)
1 期
Trial of hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care settingCovid-19 infection
EUCTR2020-002038-33-FIPorin kaupunki600
进行中(未招募)
3 期
Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus
RBR-9d8z6mHospital do Coração
进行中(未招募)
1 期
PROTECT: studio randomizzato con idrossiclorochina vs osservazione per la prevenzione e il trattamento precoce della malattia da coronavirus (COVID-19)Group 1: SARS-CoV-2-exposed subjects, as household members/contacts of COVID-19 patientsGroup 2: Patients with COVID-19 asymptomatic or paucisymptomatic in home situationMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862
EUCTR2020-001501-24-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS2,300
A randomized controlled trial of hydroxychloroquine... | 临床试验